TEM announces the acquisition of Deep 6 AI, enhancing its AI-driven clinical trial matching capabilities to accelerate patient recruitment and revolutionize precision medicine.

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

Tempus AI (TEM) announced it has acquired Deep 6 AI. Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

We recently published a list of Top 10 Stocks Everyone Is Talking About These Days. In this article, we are going to take a ...

More than 5 years after the American Society of Clinical Oncology warned of emerging disparities in precision medicine, ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

You won’t believe what’s happening in the AI startup space right now. It’s absolute madness and I mean that in the best ...

Cancer immunotherapy is a therapy used to treat cancer patients that involves or uses components of the immune system. Some cancer immunotherapies consist of antibodies that bind to, and inhibit ...

Colon cancer occurs when cells in your large intestine grow out of control. Treatment can vary by the stage and type of colon cancer. Colon cancer is a type of cancer that starts in your colon ...